Torrent Pharmaceuticals To Commence Open Offer for J.B. Chemicals

Torrent Pharmaceuticals, through NovaaOne Capital, announces an open offer to acquire up to 4,17,45,264 equity shares of J.B. Chemicals & Pharmaceuticals Limited, representing 26.00% of the expanded share capital. The offer, beginning November 18, 2025, is priced at ₹1,639.18 per share. The Offer size is valued up to INR 6,842.80 million. This offer follows Torrent’s share purchase agreements with J.B. Chemicals’ promoter and other selling shareholders.

Open Offer Details

Torrent Pharmaceuticals, managed by NovaaOne Capital Private Limited, has announced an open offer to acquire up to 4,17,45,264 fully paid-up equity shares of J.B. Chemicals & Pharmaceuticals Limited. This represents 26.00% of the expanded share capital.

Financial Aspects

The offer price is set at ₹1,639.18 per equity share, payable in cash. The aggregate value of this offer reaches up to INR 6,842.80 million. according to the document provided.

Offer Period

The tendering period for the open offer is scheduled as follows:
• Offer Opens: November 18, 2025
• Offer Closes: December 1, 2025

Share Acquisition Agreements

This open offer follows share purchase agreements where Torrent has agreed to acquire shares from existing promoter: Tau Investment Holdings Pte. Ltd. and other selling shareholders. The promoter is expected to be re-classified as a public shareholder after this transaction.

Purpose of the Offer

This acquisition aims to bolster Torrent’s strategic position, allowing for better operational synergies between the two entities, while simultaneously increasing the scale of sustainable growth for the consolidated organization.

Revised Dates

The schedule of activities have been revised. The last date for SEBI observations is now October 30, 2025, and identified date is now November 3, 2025. The tendering period will begin on November 18, 2025.

Source: BSE

InvestyWise News
InvestyWise News
Covers market-moving news with speed and precision, delivering sharp insights to help readers stay ahead in the fast-paced world of stocks.

Latest articles

Related articles

Leave a reply

Please enter your comment!
Please enter your name here
Captcha verification failed!
CAPTCHA user score failed. Please contact us!